查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
动静脉瘻管 (AVF) 设备市场规模、份额、趋势分析报告：按类型、最终用途、按地区、细分市场预测，2023-2030 年
市场调查报告书
商品编码
1321412

动静脉瘻管 (AVF) 设备市场规模、份额、趋势分析报告：按类型、最终用途、按地区、细分市场预测，2023-2030 年

Arteriovenous Fistula Devices Market Size, Share & Trends Analysis Report By Type (AVF Creation Devices, AVF Monitoring Devices, AVF Maintenance Devices), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

动静脉内瘻管 (AVF) 器材市场成长与趋势

Grand View Research 的最新报告显示，到 2030 年，全球动静脉内瘘 (AVF) 设备市场预计将达到 5.566 亿美元。

预计2023年至2030年该市场将以7.6%的年复合成长率成长。 AVF 是动脉和静脉之间的异常连接，可能由先天要素、创伤或外科手术引起。这些异常连接经常在四肢和内臟器官（包括肝臟和大脑）中观察到。在医学上，AVF 是专门为需要血液透析的末期肾臟病 (ESRD) 患者创建的。透过创建 AVF，医疗保健提供者可以建立可靠且永久的血流接入点，以进行有效的透析治疗。

AVF 设备市场受到多种要素的推动，包括需要血液透析的 ESRD 盛行率不断上升，而 AVF 的创建是为了为透析治疗提供可靠的血管通路。此外，血管内治疗和栓塞等微创手术的进步正在推动对 AVF 设备的需求。

主要参与者正在积极实施收购、合併、联盟和强大的研发活动等策略性倡议，以增强其在市场上的主导地位。这些措施旨在加强产品系列、扩大我们的市场份额并推动 AVF 设备技术的创新。

例如，VentureMed Group 于 2022 年 5 月完成了一项名为「PTA 前的 Flex Vessel Prep 用于治疗天然 AVF 阻塞性病变」的随机对照试验 (RCT) 的入组。此临床试验评估了在经皮成形术 (PTA) 之前使用 Flex 血管准备系统治疗上肢 AVF 的闭塞性病变，从而初步设计用于评估通畅性。此类研究措施在产生临床证据和证明 AVF 装置的有效性和安全性方面发挥重要作用。

因此，随着公司投资研发，我们可以期待创新设备的推出，以提高 AVF 的通畅性，最大限度地减少併发症，并为 AVF 患者提供卓越的解决方案。

AVF 设备市场报告亮点

  • 2022年，製造部门占营收份额最大，为46.97%。製造的节段在使 AVF 手术有效和成功、实现最佳透析治疗和改善患者预后方面发挥关键作用。创新的製造技术和技术进步正在提高成功率、减少併发症并改善患者照护，进一步推动该领域的成长。
  • 2022年，医院板块收入占比最大，为54.20%。这项优势归功于先进的基础设施、熟练的医疗专业人员以及报销系统要素，这些因素进一步促进了 AVF 设备在医院的使用。
  • 2022年，北美地区占据了压倒性的收入份额，达到47.59%。这一巨大的市场份额主要是由于该地区 ESRD 的患病率不断上升、对透析治疗的需求不断增加以及对有效 AVF 设备的需求。
  • 主要市场参与者包括 Medtronic、BD、Teleflex Incorporated、Fresenius Medical Care AG &Co.KGaA.、B. Braun SE、Polymedicure、NxStage Medical, Inc. 和 Laminate Medical Technologies。

目录

第1章调查方法和范围

  • 市场区隔和范围
  • 区域范围
  • 估计/预测时间表
  • 调查方法
  • 资讯采购
  • 资讯分析
  • 市场形成和资料可视化
  • 型号详情
  • 二手资讯清单

第2章执行摘要

第3章市场变数、趋势和范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 市场趋势及展望
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 营商环境分析
    • PESTLE分析
    • 波特五力分析
  • COVID-19感染疾病的影响分析

第4章业务分析的类型

  • AVF 设备市场：2022 年和 2030 年类型变化分析
  • 製造
  • 监控
  • 维护

第5章最终用途业务分析

  • AVF 设备市场：2022 年和 2030 年最终用途变化分析
  • 医院
  • 门诊手术中心
  • 透析中心

第6章区域业务分析

  • 区域市场简介
  • 北美洲
    • 北美 AVF 设备市场
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲 AVF 设备市场
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区 AVF 设备市场
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲 AVF 设备市场
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 中东/非洲 AVF 设备市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 公司分类
  • 策略规划
    • 获得
    • 合作
    • 宣布新平台
    • 其他的
  • 公司简介/名单
    • BD
    • Medtronic
    • Teleflex Incorporated
    • Fresenius Medical Care AG &Co. KGaA
    • Polymedicure
    • NxStage Medical, Inc
    • Laminate Medical Technologies
    • B. Braun SE
Product Code: GVR-4-68040-099-5

AV Fistula Devices Market Growth & Trends

The global AV fistula devices market size is expected to reach USD 556.6 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 7.6% from 2023 to 2030. AVFs are abnormal connections between arteries and veins, which can arise from congenital factors, trauma, or surgical procedures. These abnormal connections are frequently observed in both limbs and internal organs, including the liver and brain. In the context of healthcare, AVFs are deliberately established for patients suffering from End-stage Renal Disease (ESRD) who necessitate hemodialysis. By creating AVFs, healthcare providers can establish a dependable and enduring access point to the bloodstream for efficient dialysis treatments.

The market for arteriovenous fistula (AVF) devices is driven by several factors, including the rising prevalence of ESRD necessitating hemodialysis, where AVFs are created to provide reliable vascular access for dialysis treatments. In addition, advancements in minimally invasive procedures, such as endovascular techniques and embolization, have fueled the demand for AVF devices.

Key players are actively implementing strategic initiatives, including acquisitions, mergers, collaborations, and robust research and development activities, to enhance their market dominance. These initiatives aim to strengthen their product portfolios, expand their market presence, and drive innovation in AVF device technologies.

For instance, in May 2022 VentureMed Group completed the enrollment of a Randomized Controlled Trial (RCT) named 'Flex Vessel Prep before PTA for the treatment of obstructive lesions in the native AVF.' This clinical trial was designed to evaluate the primary patency at six months by utilizing the Flex Vessel Prep system before Percutaneous Transluminal Angioplasty (PTA), compared to PTA alone, for treating obstructive lesions in native AVFs in the upper extremity. Such research initiatives play a crucial role in generating clinical evidence and demonstrating the efficacy and safety of AVF devices.

Thus, as companies invest in research and development, the market can expect the introduction of innovative devices that enhance AVF patency, minimize complications, and provide superior solutions for patients with AVFs.

AV Fistulas Devices Market Report Highlights

  • In 2022, the AVF creation devices segment held the largest revenue share of 46.97%. AVF creation devices play a crucial role in enabling effective and successful AVF procedures, allowing for optimal dialysis treatment and improving patient outcomes. The advancement of innovative AVF creation technologies and techniques further drives the growth of this segment, as they offer improved success rates, reduced complications, and enhanced patient care
  • In 2022, the hospital segment held the largest revenue share of 54.20%. This dominance can be attributed to the factors such as the availability of advanced infrastructure, skilled healthcare professionals, and access to reimbursement systems that further fuel the utilization of AVF devices in hospitals
  • In 2022, North America held the dominant revenue share of 47.59%. This significant market share is primarily attributed to the increasing prevalence of ESRD in the region has led to a higher demand for dialysis treatment, creating a need for effective AVF devices
  • Key market players include Medtronic; BD; Teleflex Incorporated; Fresenius Medical Care AG & Co. KGaA., B. Braun SE; Polymedicure; NxStage Medical, Inc.; and Laminate Medical Technologies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Arteriovenous Fistulas Device (AVF) Market: Type Movement Analysis, 2022 & 2030
  • 4.2. AVF Creation Devices
    • 4.2.1. AVF Creation Devices Market, 2018 - 2030 (USD Million)
      • 4.2.1.1. Surgical Instruments
      • 4.2.1.1.1. Surgical Instruments Market, 2018 - 2030 (USD Million)
      • 4.2.1.2. Vascular Grafts
      • 4.2.1.2.1. Vascular Grafts Market, 2018 - 2030 (USD Million)
      • 4.2.1.3. Angioplasty Balloons
      • 4.2.1.3.1. Angioplasty Balloons Market, 2018 - 2030 (USD Million)
      • 4.2.1.4. Others
      • 4.2.1.4.1. Others Market, 2018 - 2030 (USD Million)
  • 4.3. AVF Monitoring Devices
    • 4.3.1. AVF Monitoring Devices Market, 2018 - 2030 (USD Million)
      • 4.3.1.1. Doppler Ultrasound
      • 4.3.1.1.1. Doppler Ultrasound Market, 2018 - 2030 (USD Million)
      • 4.3.1.2. Pressure Monitoring Systems
      • 4.3.1.2.1. Pressure Monitoring Systems Market, 2018 - 2030 (USD Million)
      • 4.3.1.3. Others
      • 4.3.1.3.1. Others Market, 2018 - 2030 (USD Million)
  • 4.4. AVF Maintenance Devices
    • 4.4.1. AVF Maintenance Devices Market, 2018 - 2030 (USD Million)
      • 4.4.1.1. Central Venous Catheters
      • 4.4.1.1.1. Central Venous Catheters Market, 2018 - 2030 (USD Million)
      • 4.4.1.2. Stents
      • 4.4.1.2.1. Stents Market, 2018 - 2030 (USD Million)
      • 4.4.1.3. Others
      • 4.4.1.3.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. End-Use Business Analysis

  • 5.1. Arteriovenous Fistulas Device (AVF) Market: End-use Movement Analysis, 2022 & 2030
  • 5.2. Hospitals
    • 5.2.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 5.3. Ambulatory Surgical Centers
    • 5.3.1. Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • 5.4. Dialysis Centers
    • 5.4.1. Dialysis Centers Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Regional Market Snapshot
  • 6.2. North America
    • 6.2.1. North America Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.2.2.2. Key Country Dynamics
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. Competitive Scenario
    • 6.2.3. Canada
      • 6.2.3.1. Canada Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.2.3.2. Key Country Dynamics
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Competitive Scenario
  • 6.3. Europe
    • 6.3.1. Europe Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
    • 6.3.2. Germany
      • 6.3.2.1. Germany Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.2.2. Key Country Dynamics
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. Competitive Scenario
    • 6.3.3. UK
      • 6.3.3.1. UK Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.3.2. Key Country Dynamics
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Competitive Scenario
    • 6.3.4. France
      • 6.3.4.1. France Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.4.2. Key Country Dynamics
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Competitive Scenario
    • 6.3.5. Italy
      • 6.3.5.1. Italy Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.5.2. Key Country Dynamics
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Competitive Scenario
    • 6.3.6. Spain
      • 6.3.6.1. Spain Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.6.2. Key Country Dynamics
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Competitive Scenario
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.7.2. Key Country Dynamics
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Competitive Scenario
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.8.2. Key Country Dynamics
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Competitive Scenario
    • 6.3.9. Norway
      • 6.3.9.1. Norway Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.9.2. Key Country Dynamics
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Competitive Scenario
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.4.2.2. Key Country Dynamics
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Competitive Scenario
    • 6.4.3. China
      • 6.4.3.1. China Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.4.3.2. Key Country Dynamics
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Competitive Scenario
    • 6.4.4. India
      • 6.4.4.1. India Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.4.4.2. Key Country Dynamics
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Competitive Scenario
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.4.5.2. Key Country Dynamics
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Competitive Scenario
    • 6.4.6. Australia
      • 6.4.6.1. Australia Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.4.6.2. Key Country Dynamics
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Competitive Scenario
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.4.7.2. Key Country Dynamics
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Competitive Scenario
  • 6.5. Latin America
    • 6.5.1. Latin America Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.5.2.2. Key Country Dynamics
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Competitive Scenario
    • 6.5.3. Mexico
      • 6.5.3.1. Mexico Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.5.3.2. Key Country Dynamics
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Competitive Scenario
    • 6.5.4. Argentina
      • 6.5.4.1. Argentina Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.5.4.2. Key Country Dynamics
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Competitive Scenario
  • 6.6. MEA
    • 6.6.1. MEA Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.6.2.2. Key Country Dynamics
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Competitive Scenario
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.6.3.2. Key Country Dynamics
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Competitive Scenario
    • 6.6.4. UAE
      • 6.6.4.1. UAE Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.6.4.2. Key Country Dynamics
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Competitive Scenario
    • 6.6.5. Kuwait
      • 6.6.5.1. UAE Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.6.5.2. Key Country Dynamics
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Competitive Scenario

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
    • 7.2.1. Acquisition
    • 7.2.2. Collaborations
    • 7.2.3. New Platform Launches
    • 7.2.4. Others
  • 7.3. Company Profiles/Listing
    • 7.3.1. BD
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Platform Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Medtronic
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Platform Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Teleflex Incorporated
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Platform Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Fresenius Medical Care AG & Co. KGaA
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Platform Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Polymedicure
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Platform Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. NxStage Medical, Inc
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Platform Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Laminate Medical Technologies
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Platform Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. B. Braun SE
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Platform Benchmarking
      • 7.3.8.4. Strategic Initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 3 Global Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 Global Arteriovenous Fistulas (AVF) devices market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America Arteriovenous Fistulas (AVF) devices market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 7 North America Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe Arteriovenous Fistulas (AVF) devices market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 14 Europe Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Germany Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 16 Germany Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 UK Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 18 UK Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 France Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 20 France Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Italy Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 22 Italy Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Spain Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 24 Spain Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Denmark Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 26 Denmark Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Sweden Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 28 Sweden Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Norway Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 30 Norway Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific Arteriovenous Fistulas (AVF) devices market, by country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 China Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 34 China Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Japan Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 36 Japan Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 India Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 38 India Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 South Korea Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 40 South Korea Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Australia Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 42 Australia Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Thailand Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 44 Thailand Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America Arteriovenous Fistulas (AVF) devices market, by country, 2018 - 2030 (USD Million)
  • Table 46 Latin America Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 47 Latin America Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Brazil Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 49 Brazil Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Mexico Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 51 Mexico Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Argentina Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 53 Argentina Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Middle East & Africa Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Africa Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 57 South Africa Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 UAE Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 61 UAE Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Kuwait Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 63 Kuwait Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Arteriovenous fistulas (AVF) devices market segmentation
  • Fig. 7 Market snapshot, 2022
  • Fig. 8 Market trends & outlook
  • Fig. 9 Market driver relevance analysis (current & future impact)
  • Fig. 10 Market restraint relevance analysis (current & future impact)
  • Fig. 11 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 Global Arteriovenous Fistulas (AVF) devices market: Type Outlook Key Takeaways
  • Fig. 14 Global Arteriovenous Fistulas (AVF) devices market: Type Movement Analysis
  • Fig. 15 Global AVF creation devices Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 16 Global AVF monitoring devices Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 17 Global AVF maintenance devices Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 18 Global Arteriovenous Fistulas (AVF) devices market: End-use Outlook Key Takeaways
  • Fig. 19 Global Arteriovenous Fistulas (AVF) devices market: End-use Movement Analysis
  • Fig. 20 Global hospital market, 2018 - 2030 (USD Million)
  • Fig. 21 Global ambulatory surgical centers market, 2018 - 2030 (USD Million)
  • Fig. 22 Global dialysis centers market, 2018 - 2030 (USD Million)
  • Fig. 23 Regional Marketplace: Key Takeaways
  • Fig. 24 Regional outlook, 2022 & 2030
  • Fig. 25 Global Arteriovenous Fistulas (AVF) devices market: Regional Movement Analysis
  • Fig. 26 North America Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 28 Canada Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 30 Germany Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 31 UK Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 32 France Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 37 Norway Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 39 Japan Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 40 China Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 41 India Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 52 UAE Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)